Pulmonary hypertension (PH) has a high mortality rate if untreated. Unfortunately, the disease is not consistently diagnosed or treated across the United States. To improve the diagnosis and care of ...

Pulmonary hypertension life expectancy and prognosis can vary broadly, but have improved in the era of modern treatment.

Women with pulmonary hypertension have a lower risk of death than men, suggesting sex should be considered as a risk factor, ...

Advanced imaging, like 4D-flow CMR, aids in understanding PA remodeling in different PH subtypes, offering non-invasive differentiation. PAH patients exhibit distinct PA flow characteristics, ...

With many pulmonary arterial hypertension (PAH) patients already taking Johnson & Johnson’s Opsumit (macitentan) or United Therapeutics' Adcirca (tadalafil), J&J has been pursuing a potential ...

Echocardiography Echocardiography in association with CPX may provide a more thorough evaluation of CV and pulmonary physiology in patients with suspected PAH, although research is needed in this area ...

Higher levels of fetal hemoglobin may guard against lung problems and delay bone damage in people with sickle cell disease, ...

A higher pulmonary vascular resistance index during exercise, but not at rest, predicts poor clinical outcomes in adults with ...